Katrin Uhlig M.D.

Katrin Uhlig, MD, MS has extensive experience in the field of medicine, specifically in clinical development and medical risk management. Katrin currently holds the position of Senior Medical Director and Head of Medical Risk Management at Agios Pharmaceuticals. In this role, they proactively assess and evaluates safety data to understand and communicate the benefit-risk profile of drugs in development and post-marketing. Katrin is also responsible for safety components in various regulatory documents.

Prior to their current role, Dr. Uhlig worked as a Senior Medical Director in Clinical Development for Rare Genetic Diseases at Agios Pharmaceuticals from 2018 to 2022. Katrin also held similar positions at Keryx Biopharmaceuticals and Quintiles, where they played key roles in clinical development.

Dr. Uhlig has academic experience as well, serving as an Adjunct Associate Professor at Tufts University School of Medicine since 2013. Katrin has also worked as an attending nephrologist and clinical researcher at Tufts Medical Center, where they conducted clinical research in nephrology.

Katrin began their medical career as an Internal Medicine Resident at Georgetown University Medical Center and later worked as a physician at Ludwig-Maximilians-Universität (LMU) München.

Overall, Dr. Katrin Uhlig has a diverse background in both academic and industry settings, with a focus on clinical development and medical risk management.

Katrin Uhlig, MD MS has an extensive education history that spans several institutions and fields of study. Katrin began their academic journey in 1980 at Pearson College UWC, where they pursued an International Baccalaureate degree until 1982. After completing their secondary education, they enrolled at RWTH Aachen University in 1982 and spent seven years studying Medicine, earning both an MD and Dr. med. degree.

In 2001, Uhlig furthered their education by attending Tufts University, where they obtained a Master of Science (MS) degree in Clinical Care Research. This program allowed their to hone their expertise in this specific field of study.

Most recently, in 2019 to 2020, Uhlig attended the University of California, San Francisco, where they pursued a Certification in the American Course on Drug Development and Regulatory Sciences (ACDRS). This program provided their with specialized knowledge and training in the intricate processes of drug development and regulatory sciences.

Overall, Katrin Uhlig, MD MS has a strong educational background in Medicine, Clinical Care Research, and Drug Development and Regulatory Sciences, which have equipped their with the necessary knowledge and skills to excel in their professional career.